SCHEMBL16206243

SCHEMBL16206243

CCCCCC(NC(=O)OC)C(C)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZDHHC7 Q9NXF8 1/20 0.44
EPHX1 P07099 1/20 0.44
CTSK P43235 2/20 0.41
SIRT1 Q96EB6 2/20 0.41
SIRT6 Q8N6T7 1/20 0.41
PLA2G2A P14555 1/20 0.40
CTSS P25774 1/20 0.39
NOD1 Q9Y239 1/20 0.39
FAAH O00519 1/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 1/20 0.39
MEN1 O00255 1/20 0.39
HPGD P15428 1/20 0.39
RECQL P46063 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PLA2G2C Q5R387 1/20 0.38
GPR84 Q9NQS5 3/20 0.37
FFAR1 O14842 1/20 0.37
BIRC2 Q13490 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12661112 0.94 CTSK (0.45) ZDHHC7EPHX1CTSKCTSSCA1
SCHEMBL12661111 0.86 CTSK (0.41) ZDHHC7EPHX1CTSKCTSSCA1
SCHEMBL890099 0.86 CTSK (0.41) ZDHHC7EPHX1CTSKCTSSCA1
SCHEMBL12630385 0.86 CTSK (0.41) ZDHHC7EPHX1CTSKCTSSCA1
SCHEMBL7123665 0.84 NOD1 (0.57) ZDHHC7EPHX1SIRT1NOD1MEN1
SCHEMBL29299766 0.83 CTSK (0.61) CTSKCTSS
SCHEMBL18123014 0.83 CTSK (0.61) CTSKCTSS
SCHEMBL20435333 0.82 SIRT6 (0.55) ZDHHC7SIRT1SIRT6PLA2G2ANOD1
SCHEMBL14978808 0.82 SIRT6 (0.55) ZDHHC7SIRT1SIRT6PLA2G2ANOD1
SCHEMBL10167182 0.82 EPHX1 (0.50) EPHX1SIRT1SIRT6CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9421275-B2 Oligomer-calcimimetic conjugates and related compunds NEKTAR THERAPEUTICS (US) 2016-08-23 US disclosed
US-20140328791-A1 Conjugates of an IL-2 Moiety and a Polymer NEKTAR THERAPEUTICS 2014-11-06 US disclosed
US-20140323565-A1 Oligomer-Calcimimetic Conjugates and Related Compunds NEKTAR THERAPEUTICS (US) 2014-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140328791-A1 Conjugates of an IL-2 Moiety and a Polymer IL2, IL2RA, ILF2 ZDHHC7 1458/4885EPHX1 2620/4885CTSK 1672/4885
US-20140323565-A1 Oligomer-Calcimimetic Conjugates and Related Compunds CALCR, CALCB, CALCA ZDHHC7 3443/4885EPHX1 2587/4885CTSK 699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.